{"id":"CHEMBL100116","canonicalSmiles":"CC(C)=CCN1CCC2(C)c3cc(O)ccc3CC1C2C","inchiKey":"VOKSWYLNZZRQPF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PENTAZOCINE","yearOfFirstApproval":1967,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Fortral","Talwin"],"synonyms":["NSC-107430","Pentazocine","Pentazocine civ","WIN 20,228","WIN-20228"],"childChemblIds":["CHEMBL3989509","CHEMBL3989510"],"count":2,"approvedIndications":["EFO_0003843"],"linkedTargets":{"rows":["ENSG00000147955"],"count":1},"linkedDiseases":{"rows":["EFO_0000289","EFO_0003843"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1967 and is indicated for pain and has 1 investigational indication."}
{"id":"CHEMBL101309","canonicalSmiles":"CC(C)c1cc(C(C)C)c(CC(=O)NS(=O)(=O)Oc2c(C(C)C)cccc2C(C)C)c(C(C)C)c1","inchiKey":"PTQXTEKSNBVPQJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AVASIMIBE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Avasimibe","CI-1011"],"crossReferences":{"drugbank":["DB06442"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL105184","canonicalSmiles":"COC(=O)c1cc(OC)c2c(c1-c1c(C(=O)OC)cc(OC)c3c1OCO3)OCO2","inchiKey":"JMZOMFYRADAWOG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BIFENDATE","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bifendate"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL107316","canonicalSmiles":"COc1cc2c(cc1OC)C(=O)[C@H](CC1CCN(Cc3ccccc3)CC1)C2","inchiKey":"ADEBPBSSDYVVLD-HXUWFJFHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL107316","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07701"],"chEBI":["53292"]},"childChemblIds":["CHEMBL2448118"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL109227","canonicalSmiles":"OB(O)c1ccc(-c2ccc(B(O)O)cc2)cc1","inchiKey":"SLHKDOGTVUCXKX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"4,4'-Biphenyldiboronic Acid","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["4,4'-Biphenyldiboronic Acid"],"crossReferences":{"drugbank":["DB02627"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1162483","canonicalSmiles":"CC[C@@H](C)C(=O)O","inchiKey":"WLAMNBDJUVNPJU-SCSAIBSYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"(R)-2-Methylbutanoate","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["(R)-2-Methylbutanoate"],"crossReferences":{"drugbank":["DB03741"],"chEBI":["45525"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1179047","canonicalSmiles":"CCN(CC)CCOC(=O)c1ccc(N)cc1Cl","inchiKey":"VDANGULDQQJODZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHLOROPROCAINE","yearOfFirstApproval":1955,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Chloroprocaine"],"crossReferences":{"DailyMed":["chloroprocaine%20hydrochloride"],"Wikipedia":["Chloroprocaine"],"drugbank":["DB01161"],"chEBI":["3636"]},"childChemblIds":["CHEMBL944"],"count":2,"linkedTargets":{"rows":["ENSG00000153253","ENSG00000185313","ENSG00000183873","ENSG00000136546","ENSG00000144285","ENSG00000169432","ENSG00000168356","ENSG00000007314","ENSG00000136531","ENSG00000196876"],"count":10},"linkedDiseases":{"rows":["EFO_0007202","EFO_0003843","EFO_0002950"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1955 and has 2 investigational indications."}
{"id":"CHEMBL1182997","canonicalSmiles":"COc1cc2c(cc1OC)[C@H](c1cc(OC)c(OC)c(OC)c1)[N@@+](C)(CCCOC(=O)/C=C(\\Cl)C(=O)OCCC[N@+]1(C)CCc3cc(OC)c(OC)cc3[C@H]1Cc1cc(OC)c(OC)c(OC)c1)CC2","inchiKey":"ZQLDXCSTJFLRPY-RWBXLJKRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GANTACURIUM","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB05710"]},"childChemblIds":["CHEMBL275321"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1193","canonicalSmiles":"CN(C)CCC(c1ccccc1)c1ccccn1","inchiKey":"IJHNSHDBIRRJRN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PHENIRAMINE","yearOfFirstApproval":1994,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["NSC-47965","Pheniramine"],"crossReferences":{"DailyMed":["pheniramine%20maleate"],"PubChem":["90341510"],"Wikipedia":["Pheniramine"],"drugbank":["DB01620"]},"childChemblIds":["CHEMBL1596440","CHEMBL1580221","CHEMBL1653"],"count":3,"approvedIndications":["HP_0000989","EFO_0003785"],"linkedTargets":{"rows":["ENSG00000196639"],"count":1},"linkedDiseases":{"rows":["HP_0000989","EFO_0007328","EFO_0007141","MONDO_0024355","EFO_0003785","EFO_0007214"],"count":6},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1994 and is indicated for pruritus and allergy and has 1 investigational indication."}
{"id":"CHEMBL1198148","canonicalSmiles":"CC[C@@H](N)C(=O)N1CCC[C@H]1C(=O)NCc1ccc(C(=N)N)cc1","inchiKey":"YHAMQFKGUUSJMU-KGLIPLIRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1198148","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB06947"]},"childChemblIds":["CHEMBL597202","CHEMBL3423206"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1200321","canonicalSmiles":"Cc1noc(NS(=O)(=O)c2ccc(N)cc2)c1C.OCCNCCO","inchiKey":"FEPTXVIRMZIGFY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SULFISOXAZOLE DIOLAMINE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL453","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Gantrisin","Sulfisoxazole diolamine"],"synonyms":["NU-445","Sulfisoxazole diolamine"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982."}
{"id":"CHEMBL1200348","canonicalSmiles":"Clc1ccc(CSC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1.O=[N+]([O-])O","inchiKey":"CRKGMGQUHDNAPB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SULCONAZOLE NITRATE","yearOfFirstApproval":1985,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1221","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Exelderm"],"synonyms":["RS-44872","RS-44872-00-10-3","RS-44872-00-1O-3","Sulconazole nitrate"],"crossReferences":{"DailyMed":["sulconazole%20nitrate"],"PubChem":["144204222","170465344","26748515","26748516","50107420","50107421","56422432","855903"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1985."}
{"id":"CHEMBL1200450","canonicalSmiles":"Cc1ccc(/C(=C\\CN2CCCC2)c2ccccn2)cc1.Cl","inchiKey":"WYUYEJNGHIOFOC-NWBUNABESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRIPROLIDINE HYDROCHLORIDE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL855","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Actidil","Myidyl","Triprolidine HCl"],"synonyms":[],"crossReferences":{"PubChem":["11533048","26747669","26747670","50107044","56422884"],"chEBI":["84119"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1200485","canonicalSmiles":"CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1.Cc1ccc(S(=O)(=O)O)cc1","inchiKey":"IVDHYUQIDRJSTI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SORAFENIB TOSYLATE","yearOfFirstApproval":2005,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1336","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Nexavar"],"synonyms":["BAY 54-9085","BAY-54-9085","Sorafenib tosilate","Sorafenib tosylate"],"crossReferences":{"DailyMed":["sorafenib%20tosylate"],"PubChem":["144206042","170465175","85147444"],"chEBI":["50928"]},"count":57,"linkedTargets":{"rows":["ENSG00000128052","ENSG00000165731","ENSG00000102755","ENSG00000037280","ENSG00000157764","ENSG00000157404","ENSG00000113721","ENSG00000132155","ENSG00000122025"],"count":9},"linkedDiseases":{"rows":["EFO_0000637","EFO_0000365","EFO_0000756","EFO_0000681","EFO_1000657","EFO_1001052","EFO_1001951","EFO_0000588","EFO_0000389","MONDO_0008903","EFO_0000182","EFO_0000501","EFO_0000641","EFO_0002618","EFO_0000220","MONDO_0002108","MONDO_0008170","EFO_0000349","EFO_0009907","EFO_1001968","EFO_0000224","MONDO_0008315","EFO_1001967","MONDO_0002691","MONDO_0044787","EFO_0003032","MONDO_0000544","EFO_0000335","EFO_1000613","EFO_0001378","MONDO_0021640","EFO_0000292","EFO_0002938","MONDO_0004192","EFO_1001465","MONDO_0007254","EFO_0003871","EFO_1001469","MONDO_0021063","MONDO_0002087","MONDO_0044937","MONDO_0020654","MONDO_0001187","MONDO_0002158","EFO_1000044","EFO_0006352","EFO_0000673","EFO_0002499","MONDO_0020743","EFO_1000158","EFO_0002914","EFO_0000616","MONDO_0019457","Orphanet_44890","EFO_0000403","EFO_0000222","EFO_0002501","EFO_0007535","MONDO_0021038","EFO_0003060","EFO_0000640","EFO_0006861","EFO_0000095","EFO_0000702","MONDO_0017386","MONDO_0002367","MONDO_0024880","EFO_0000691","EFO_0000519","MONDO_0044926"],"count":70},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2005 and has 57 investigational indications."}
{"id":"CHEMBL1200502","canonicalSmiles":"CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O.O","inchiKey":"HQUPLSLYZHKKQT-WVVFQGGUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AZITHROMYCIN MONOHYDRATE","maximumClinicalTrialPhase":2,"parentId":"CHEMBL529","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Azithromycin monohydrate"],"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL1200619","canonicalSmiles":"Nc1nc(NC2CC2)c2ncn([C@H]3C=C[C@@H](CO)C3)c2n1.O=S(=O)(O)O","inchiKey":"MBFKCGGQTYQTLR-SCYNACPDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ABACAVIR SULFATE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1380","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Abacavir Sulfate","Ziagen"],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1200660","canonicalSmiles":"O[C@H]1CO[C@@H]2[C@H](O)CO[C@H]12","inchiKey":"KLDXJTOLSGUMSJ-JGWLITMVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ISOSORBIDE","yearOfFirstApproval":1974,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ismotic"],"synonyms":["AT-101","Isosorbide","NSC-40725"],"crossReferences":{"PubChem":["170465187","29216190","29218044","29218045"],"Wikipedia":["Isosorbide"],"drugbank":["DB09401"]},"count":12,"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1974 and has 12 investigational indications."}
{"id":"CHEMBL1200756","canonicalSmiles":"Cc1ncc(CO)c(CO)c1O.Cl","inchiKey":"ZUFQODAHGAHPFQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PYRIDOXINE HYDROCHLORIDE","maximumClinicalTrialPhase":4,"parentId":"CHEMBL1364","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Beesix","Benadon","Comploment continus","Hexa-betalin","Kent b6","Lyphomed","Orovite comploment b6","Pyrid-10","Pyrid-20","Pyridox hcl","Pyridox-roche","Pyridoxine hydrochloride","Pyridoxol Hcl","Vital foods","Vitalife","Vitamin B6"],"synonyms":["NSC-36225","Pyridoxine hydrochloride","Vitamin b6"],"crossReferences":{"DailyMed":["pyridoxine%20hydrochloride"],"PubChem":["144212793","26757736","51085174"],"chEBI":["30961"]},"count":6,"approvedIndications":["EFO_0004272","EFO_0001070","HP_0001891"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and has 3 approved and 3 investigational indications."}
{"id":"CHEMBL1200774","canonicalSmiles":"C[C@]12C[C@H](O)[C@H]3[C@@H](C[C@H](F)C4=CC(=O)C=C[C@@]43C)[C@@H]1CC[C@]2(O)C(=O)CO","inchiKey":"MYYIMZRZXIQBGI-HVIRSNARSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FLUPREDNISOLONE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Alphadrol"],"synonyms":["Fluprednisolone","U-7800"],"crossReferences":{"PubChem":["144205251","144206694","170465086"],"Wikipedia":["Fluprednisolone"],"drugbank":["DB09378"],"chEBI":["34474"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982."}
{"id":"CHEMBL1200795","canonicalSmiles":"CN1CCC[C@@H]1CCO[C@](C)(c1ccccc1)c1ccc(Cl)cc1.O=C(O)/C=C/C(=O)O","inchiKey":"PMGQWSIVQFOFOQ-YKVZVUFRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CLEMASTINE FUMARATE","yearOfFirstApproval":1977,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1626","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Clemastine fumarate","Tavegil","Tavist","Tavist-1"],"synonyms":["Clemastine fumarate","Clemastine hydrogen fumarate"],"crossReferences":{"DailyMed":["clemastine%20fumarate"],"PubChem":["144204125","170465318","93576607"],"chEBI":["3739"]},"count":2,"linkedTargets":{"rows":["ENSG00000196639"],"count":1},"linkedDiseases":{"rows":["EFO_0003885","EFO_0003785"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1977 and has 2 investigational indications."}
{"id":"CHEMBL1200803","canonicalSmiles":"O=C(O)CCC(=O)O.O=C(O[C@H]1CN2CCC1CC2)N1CCc2ccccc2[C@@H]1c1ccccc1","inchiKey":"RXZMMZZRUPYENV-VROPFNGYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SOLIFENACIN SUCCINATE","yearOfFirstApproval":2004,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1734","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Solifenacin succinate","Vesicare","Vesicare ls"],"synonyms":["Solifenacin succinate","YM-67905","YM-905","YM67905","YM905"],"crossReferences":{"DailyMed":["solifenacin%20succinate"]},"count":2,"approvedIndications":["EFO_1000781"],"linkedTargets":{"rows":["ENSG00000133019","ENSG00000181072"],"count":2},"linkedDiseases":{"rows":["EFO_0003103","HP_0000020","EFO_1000781","EFO_0000284","HP_0011277"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2004 and is indicated for overactive bladder and has 1 investigational indication."}
{"id":"CHEMBL1201035","canonicalSmiles":"Cl.OC(CCN1CCCCC1)(c1ccccc1)C1CC2C=CC1C2","inchiKey":"RDNLAULGBSQZMP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BIPERIDEN HYDROCHLORIDE","yearOfFirstApproval":1959,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1101","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Akineton","Akineton ret"],"synonyms":["Biperiden hydrochloride","NSC-170950","NSC-84989"],"crossReferences":{"PubChem":["144206338","144206615","170465324"],"chEBI":["59171"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1959."}
{"id":"CHEMBL1201150","canonicalSmiles":"CNS(=O)(=O)Cc1ccc2[nH]cc(CCN(C)C)c2c1.O=C(O)CCC(=O)O","inchiKey":"PORMUFZNYQJOEI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SUMATRIPTAN SUCCINATE","yearOfFirstApproval":1992,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL128","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Alsuma","Imigran","Imigran 50","Imigran radis","Imigran recovery","Imigran subject","Imitrex","Imitrex statdose","Migraitan","Migraleve ultra","Onzetra xsail","Sumatriptan succinate","Sumavel dosepro","Zecuity","Zembrace symtouch"],"synonyms":["GR 43175C","GR-43175C","Sumatriptan succinate"],"crossReferences":{"DailyMed":["sumatriptan%20succinate"],"PubChem":["49681638"],"chEBI":["64359"]},"count":3,"approvedIndications":["EFO_0003821"],"linkedTargets":{"rows":["ENSG00000135312","ENSG00000179546"],"count":2},"linkedDiseases":{"rows":["EFO_0005296","EFO_0003821","EFO_0005295","HP_0002315"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1992 and is indicated for migraine disorder and has 2 investigational indications."}
{"id":"CHEMBL1201171","canonicalSmiles":"CCCCOc1ccc(OCCCN2CCOCC2)cc1.Cl","inchiKey":"SYCBXBCPLUFJID-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PRAMOXINE HYDROCHLORIDE","yearOfFirstApproval":1976,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1198","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Tronolane","Tronothane"],"synonyms":["Pramoxine hydrochloride"],"crossReferences":{"DailyMed":["pramoxine%20hydrochloride"],"PubChem":["144204028","170465004","26748507","855556"]},"count":1,"approvedIndications":["MP_0001845"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1976 and is indicated for inflammation."}
{"id":"CHEMBL1201177","canonicalSmiles":"CC(C)(C)NC[C@H](O)COc1cccc2c1CCCC2=O.Cl","inchiKey":"DNTDOBSIBZKFCP-YDALLXLXSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LEVOBUNOLOL HYDROCHLORIDE","yearOfFirstApproval":1985,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1201237","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Akbeta","Betagan","Levobunolol hydrochloride"],"synonyms":["Levobunolol hydrochloride","W 7000A","W-7000A"],"crossReferences":{"DailyMed":["levobunolol%20hydrochloride"],"PubChem":["144204168","170464743","56463666"],"chEBI":["6439"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1985."}
{"id":"CHEMBL1201347","canonicalSmiles":"CCOC(=O)C1(c2ccccc2)CCN(CCc2ccc(N)cc2)CC1","inchiKey":"LKYQLAWMNBFNJT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ANILERIDINE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Anileridine"],"crossReferences":{"PubChem":["170465266"],"Wikipedia":["Anileridine"],"drugbank":["DB00913"],"chEBI":["61203"]},"childChemblIds":["CHEMBL1200543","CHEMBL1201047"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982."}
{"id":"CHEMBL1201441","drugType":"Small molecule","blackBoxWarning":false,"name":"COLISTIMETHATE SODIUM","yearOfFirstApproval":1970,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Colifin 1 miu","Colifin 2 miu","Colistimethate sodium","Colobreathe","Coly-mycin","Coly-mycin m","Promixin"],"synonyms":["Colistimethate sodium","W 1929"],"crossReferences":{"DailyMed":["colistimethate%20sodium"],"DrugCentral":["731"]},"count":5,"approvedIndications":["EFO_0000544"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1970 and is indicated for infection and has 4 investigational indications."}
{"id":"CHEMBL1201764","canonicalSmiles":"CC(C)C(=O)Oc1ccc(CO)cc1[C@H](CCN(C(C)C)C(C)C)c1ccccc1","inchiKey":"DCCSDBARQIPTGU-HSZRJFAPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FESOTERODINE","yearOfFirstApproval":2008,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Fesoterodine"],"crossReferences":{"DailyMed":["fesoterodine%20fumarate"],"Wikipedia":["Fesoterodine"],"drugbank":["DB06702"]},"childChemblIds":["CHEMBL1201765"],"count":5,"approvedIndications":["HP_0000020","HP_0000103"],"linkedTargets":{"rows":["ENSG00000133019","ENSG00000181072"],"count":2},"linkedDiseases":{"rows":["HP_0000020","EFO_1001762","EFO_0000673","EFO_1000781","HP_0000011","HP_0000103"],"count":6},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2008 and is indicated for polyuria and urinary incontinence and has 3 investigational indications."}
{"id":"CHEMBL1201786","canonicalSmiles":"CCCCCCCCCCCC(=O)OCCNC(=O)C[n+]1ccccc1","inchiKey":"UGJWZYARKOFRDB-UHFFFAOYSA-O","drugType":"Small molecule","blackBoxWarning":false,"name":"LAPYRIUM","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Lapyrium"],"crossReferences":{"Wikipedia":["Lapyrium"],"drugbank":["DB09376"]},"childChemblIds":["CHEMBL1201787"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982."}
{"id":"CHEMBL1221659","canonicalSmiles":"Cc1cc(N)nc(CCNC(=O)c2ccc(C#N)cc2)c1","inchiKey":"QINCZVSBLITNRD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1221659","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07389"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1222250","canonicalSmiles":"OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O","inchiKey":"WQZGKKKJIJFFOK-GASJEMHNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DEXTROSE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Capd","Clintec","Dextro energy","Dextrogel","Gambrosol","Glucose-40","Gsf-syrup","Insta-glucose","Rapilose","Yourgluco"],"synonyms":["Dextrose","Glucose","Glucose injection","Glucose, liquid"],"crossReferences":{"DailyMed":["dextrose"],"PubChem":["144206716","144207343","29218051"],"Wikipedia":["Glucose"],"chEBI":["4167"]},"count":40,"approvedIndications":["MP_0001914","HP_0002619"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for hemorrhage and varicose veins and has 38 investigational indications."}
{"id":"CHEMBL1233860","canonicalSmiles":"CSCCC(=O)C(=O)O","inchiKey":"SXFSQZDSUWACKX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1233860","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02238"],"chEBI":["33574"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1234751","canonicalSmiles":"CC(=O)N[C@@H](CCC(=O)O)C(=O)O","inchiKey":"RFMMMVDNIPUKGG-YFKPBYRVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ACETYLGLUTAMIC ACID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144205861","170466605","29217838"],"drugbank":["DB04075"],"chEBI":["17533"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1236446","canonicalSmiles":"CCCCCCCCCCCCCC(=O)O[C@@H]1[C@@H](CC(=O)NO)CO[C@H](CO)[C@H]1O","inchiKey":"INAPDIIIYSWKOC-XHIHJMKYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1236446","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB01991"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL125200","canonicalSmiles":"Cc1cccc2c1CCNC2=O","inchiKey":"RLLZPXDJYADIEU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PD-128763","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["PD-128763"],"crossReferences":{"drugbank":["DB03722"],"chEBI":["41928"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1328968","canonicalSmiles":"C=C1C[C@H]2[C@@H]3C=C(C)C4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]2(C)[C@@]1(OC(C)=O)C(C)=O","inchiKey":"UDKABVSQKJNZBH-DWNQPYOZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MELENGESTROL ACETATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["5373","BDH 1921","Melengestrol","Melengestrol acetate"],"crossReferences":{"PubChem":["144205440","144213722","170465702","29218056","56323955"],"drugbank":["DB14659"],"chEBI":["34831"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1330588","canonicalSmiles":"Cc1cc(=O)[nH]c(=S)[nH]1","inchiKey":"HWGBHCRJGXAGEU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"METHYLTHIOURACIL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Methylthiouracil"],"crossReferences":{"PubChem":["144204639","144209068","144210815","170466508","17389816","26747305","8139888","85272317"],"drugbank":["DB13644"],"chEBI":["82346"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1355596","canonicalSmiles":"CCCCCCOc1ccc(C(=N)N(CCCC)CCCC)c2ccccc12","inchiKey":"FGGFIMIICGZCCJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BUNAMIDINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bunamidine"],"crossReferences":{"PubChem":["50125801"],"drugbank":["DB11501"]},"childChemblIds":["CHEMBL2104240"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1412","canonicalSmiles":"C1CNCCN1","inchiKey":"GLUUGHFHXGJENI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PIPERAZINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Antepar","Ascalix","Ectodyne","Expelix","Ins umuline rapide","Wormex"],"synonyms":["Piperazine"],"crossReferences":{"PubChem":["144207113","144209440","144210424","26748210"],"Wikipedia":["Piperazine"],"drugbank":["DB00592"],"chEBI":["28568"]},"count":1,"approvedIndications":["EFO_1001342"],"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for helminthiasis."}
{"id":"CHEMBL142936","canonicalSmiles":"CCN(CC)CCc1c[nH]c2ccccc12","inchiKey":"LSSUMOWDTKZHHT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIETHYLTRYPTAMINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["N,N-Diethyltryptamine"],"crossReferences":{"PubChem":["124954093"],"Wikipedia":["Diethyltryptamine"],"drugbank":["DB01460"]},"childChemblIds":["CHEMBL3184651"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1432","canonicalSmiles":"O=C(O)c1cccc(O)c1O","inchiKey":"GLDQAMYCGOIJDV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"2,3-DIHYDROXYBENZOIC ACID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["2,3-Dihydroxybenzoic Acid","2,3-Dihydroxybenzoicacid"],"crossReferences":{"PubChem":["47193697"],"Wikipedia":["2,3-Dihydroxybenzoic_acid"],"drugbank":["DB01672"],"chEBI":["18026"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL14577","canonicalSmiles":"C[n+]1ccccc1/C=N/O.[I-]","inchiKey":"QNBVYCDYFJUNLO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PRALIDOXIME IODIDE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1420","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Pralidoxime iodide"],"crossReferences":{"PubChem":["11532922"],"chEBI":["32038"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1509","canonicalSmiles":"C[C@]12CC[C@H]3[C@H]([C@@H]1[C@@H]1C[C@@H]1[C@@]21CCC(=O)O1)[C@H]1C[C@H]1C1=CC(=O)CC[C@@]13C","inchiKey":"METQSPRSQINEEU-HXCATZOESA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"DROSPIRENONE","yearOfFirstApproval":2001,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Angeliq","Slynd"],"synonyms":["Drospirenone","ZK 30595","ZK-30595"],"crossReferences":{"DailyMed":["drospirenone"],"PubChem":["144205769","170464870"],"Wikipedia":["Drospirenone"],"drugbank":["DB01395"],"chEBI":["50838"]},"count":7,"approvedIndications":["EFO_0003894"],"linkedTargets":{"rows":["ENSG00000082175","ENSG00000151623"],"count":2},"linkedDiseases":{"rows":["EFO_0005204","MONDO_0002050","EFO_1000710","MONDO_0004169","EFO_0009006","HP_0100607","EFO_0000319","EFO_0010270","EFO_0003894","EFO_0000660","EFO_0000537","EFO_0005924"],"count":12},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2001 and is indicated for acne and has 6 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL156791","canonicalSmiles":"CC(C)(C)NCC(O)COc1cc(Cl)ccc1Cl","inchiKey":"XYCMOTOFHFTUIU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CLORANOLOL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cloranolol"],"crossReferences":{"drugbank":["DB13508"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1568276","canonicalSmiles":"CCOc1ccc2ccccc2c1C(=O)N[C@@H]1C(=O)N2[C@@H](C(=O)[O-])C(C)(C)S[C@H]12.O.[Na+]","inchiKey":"OCXSDHJRMYFTMA-KMFBOIRUSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"NAFCILLIN SODIUM","yearOfFirstApproval":1965,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1443","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Nafcillin sodium","Nallpen","Unipen"],"synonyms":["Nafcillin sodium","Nafcillin sodium monohydrate","Nafcillin sodium salt anhydrous","Nafcillin sodium salt monohydrate","WY-3277"],"crossReferences":{"DailyMed":["nafcillin%20sodium"],"PubChem":["11112986","144204318","170465253","56423140"],"chEBI":["51919"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1965 and has 1 investigational indication."}
{"id":"CHEMBL1608183","canonicalSmiles":"CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C","inchiKey":"ZOCUOMKMBMEYQV-GSLJADNHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ISOFLUPREDONE ACETATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Isoflupredone","Isoflupredone acetate","U-6013"],"crossReferences":{"PubChem":["144203988","170465628","56463338","77262","94137"],"drugbank":["DB14640"],"chEBI":["34517"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1650","canonicalSmiles":"CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3C(=O)C[C@@]21C","inchiKey":"ITRJWOMZKQRYTA-RFZYENFJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CORTISONE ACETATE","yearOfFirstApproval":1950,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cortate","Cortelan","Cortisone acetate","Cortistab","Cortisyl","Cortone"],"synonyms":["Cortisone","Cortisone 21-acetate","Cortisone Acetate","Cortisone acetate","NSC-49420"],"crossReferences":{"DailyMed":["cortisone%20acetate"],"PubChem":["144207031","170464685","29214995","50103888","855514","90341460"],"drugbank":["DB01380"],"chEBI":["3897"]},"count":46,"approvedIndications":["EFO_1001896","EFO_1000997","EFO_1001205","EFO_0005319","EFO_1000764","EFO_0004274","EFO_1001435","HP_0001094","EFO_0003778","EFO_1000684","EFO_0005558","EFO_0000274","HP_0001915","EFO_0008997","EFO_0000565","HP_0004398","EFO_0007160","EFO_0009456","EFO_0002506","EFO_1000694","EFO_0002690","EFO_0004255","EFO_0003063","EFO_0004276","EFO_0005752","HP_0003072","MONDO_0043579","EFO_0000685","MONDO_0015128","EFO_1000039","HP_0001873","EFO_1000941","EFO_0002609","Orphanet_418","EFO_1001119","EFO_0003106","EFO_0000398","Orphanet_90794","EFO_0007403","EFO_0000270","EFO_1000049","EFO_0000574","EFO_1001194","EFO_0003785"],"linkedTargets":{"rows":["ENSG00000113580"],"count":1},"linkedDiseases":{"rows":["EFO_1001896","EFO_1000997","EFO_0005319","EFO_1001205","EFO_1000764","EFO_0004274","EFO_1001435","HP_0001094","EFO_0003778","EFO_1000684","EFO_0005558","EFO_0000274","HP_0001915","EFO_0008997","EFO_0000565","HP_0004398","EFO_0007160","EFO_0009456","EFO_1000694","EFO_0002506","EFO_0002690","EFO_0004255","EFO_0003063","EFO_0004276","EFO_0005752","EFO_1001250","HP_0003072","MONDO_0043579","EFO_0000685","MONDO_0015128","EFO_1000039","EFO_0005532","HP_0001873","EFO_1000941","EFO_1001119","Orphanet_418","EFO_0002609","EFO_0003106","EFO_0000398","Orphanet_90794","EFO_0007403","EFO_0000270","EFO_1000049","EFO_0000574","EFO_1001194","EFO_0003785"],"count":46},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1950 and has 44 approved and 2 investigational indications."}
{"id":"CHEMBL1663","canonicalSmiles":"FC(F)(F)C(F)(F)C(F)(F)F","inchiKey":"QYSGYZVSCZSLHT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"PERFLUTREN","yearOfFirstApproval":2001,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Definity"],"synonyms":["DMP 115","DMP-115","FS-069","FS069","MRX-115","Perfluoropropane","Perflutren"],"crossReferences":{"DailyMed":["perflutren"],"Wikipedia":["Octafluoropropane"],"drugbank":["DB00556"],"chEBI":["31980"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2001 and has 1 investigational indication. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1673195","canonicalSmiles":"CC(=O)N[C@@H]1[C@@H](N[14C](=N)N)C=C(C(=O)O)O[C@H]1[C@H](O)[C@H](O)CO","inchiKey":"ARAIBEBZBOPLMB-DWQLSOMASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"[14C]-ZANAMIVIR","maximumClinicalTrialPhase":0,"parentId":"CHEMBL222813","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Zanamivir"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1697843","canonicalSmiles":"CO[C@H]1[C@@H](O)C[C@H](O[C@H]2[C@@H](O)C[C@H](O[C@H]3[C@@H](O)C[C@H](O[C@H]4CC[C@]5(C)[C@H]6C[C@@H](O)[C@]7(C)[C@@H](C8=CC(=O)OC8)CC[C@]7(O)[C@@H]6CC[C@@H]5C4)O[C@@H]3C)O[C@@H]2C)O[C@@H]1C","inchiKey":"IYJMSDVSVHDVGT-PEQKVOOWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"METILDIGOXIN","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Lanitop"],"synonyms":["Medigoxin","Methyldigoxin","Metildigoxin"],"crossReferences":{"PubChem":["144206178"],"drugbank":["DB13401"]},"count":1,"approvedIndications":["EFO_0000319"],"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for cardiovascular disease."}
{"id":"CHEMBL1738889","canonicalSmiles":"C[C@](O)(COc1ccc(C#N)cc1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1","inchiKey":"JNGVJMBLXIUVRD-SFHVURJKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ENOBOSARM","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Ostarine"],"synonyms":["Enobosarm","GTX-024","Gtx-024","MK-2866"],"crossReferences":{"drugbank":["DB12078"]},"count":6,"linkedTargets":{"rows":["ENSG00000169083"],"count":1},"linkedDiseases":{"rows":["EFO_0009851","HP_0000020","HP_0004326","MONDO_0007254","EFO_0000305","EFO_0003060"],"count":6},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 6 investigational indications."}
{"id":"CHEMBL1743029","drugType":"Antibody","blackBoxWarning":false,"name":"IBALIZUMAB","yearOfFirstApproval":2018,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Trogarzo"],"synonyms":["HU5A8","Ibalizumab","Ibalizumab-uiyk","TNX-355"],"crossReferences":{"DailyMed":["ibalizumab-uiyk"]},"count":4,"approvedIndications":["EFO_0000764","EFO_0000180","EFO_0000763"],"linkedTargets":{"rows":["ENSG00000010610"],"count":1},"linkedDiseases":{"rows":["EFO_0000544","EFO_0000764","EFO_0000180","EFO_0000763"],"count":4},"description":"Antibody drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2018 and has 3 approved and 1 investigational indication."}
{"id":"CHEMBL1766417","canonicalSmiles":"CNC(=O)C[C@@H]1NC(=O)c2csc(n2)-c2ccc(-c3nc(C4=N[C@H](C(=O)N5CCC[C@H]5C(N)=O)CO4)cs3)nc2-c2csc(n2)-c2csc(n2)[C@H]([C@@H](O)c2ccccc2)NC(=O)CNC(=O)c2nc(sc2COC)[C@H](C(C)C)NC(=O)c2nc1sc2C","inchiKey":"JMDULECOHIXMNX-MZHFYNGJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1766417","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02975"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1788122","canonicalSmiles":"[3H]C([3H])([3H])Oc1ccc(CCN2CCC(Nc3nc4ccccc4n3Cc3ccc(F)cc3)CC2)cc1","inchiKey":"GXDALQBWZGODGZ-RLXJOQACSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"[3H]-ASTEMIZOLE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL296419","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["[3H]-Astemizole"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL184","canonicalSmiles":"Nc1nc(O)c2ncn(COCCO)c2n1","inchiKey":"MKUXAQIIEYXACX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ACYCLOVIR","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Aciclovir","Acycloguanosine","Acyclovir","Avaclyr","Avert","Aviral","Clearsore","Cyclovir","Cymex ultra","Duvimex","Herpetad","Lipsore","Lypsyl","Ranovir","Sitavig","Soothelip","Soraway","Viralief","Virasorb","Virovir 200","Virovir 400","Virovir 800","Zovirax"],"synonyms":["Aciclovir","Acyclovir","NSC-645011","Zovirax"],"crossReferences":{"DailyMed":["acyclovir","acyclovir%20sodium"],"PubChem":["11110742","11110743","124879196","144203626","170464640","174007373","26747423","50104033","50105759","50112892","855732","90341314"],"Wikipedia":["Aciclovir"],"drugbank":["DB00787"],"chEBI":["2453"]},"childChemblIds":["CHEMBL1200380"],"count":8,"approvedIndications":["EFO_1002022","EFO_1001347","EFO_0007282","EFO_0006510","EFO_1001888","EFO_0007204","EFO_0000763"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1982 and has 7 approved and 1 investigational indication."}
{"id":"CHEMBL185","canonicalSmiles":"O=c1[nH]cc(F)c(=O)[nH]1","inchiKey":"GHASVSINZRGABV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FLUOROURACIL","yearOfFirstApproval":1962,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["5.f.u.","Accusite","Actikerall","Adrucil","Carac","Efudex","Efudix","Fluoro-uracil roche","Fluoroplex","Fluorouracil","Tolak"],"synonyms":["5 FU","5-FU","5-Fluorouracil","Fluorouracil","Fluracil","NSC-19893","RO 2-9757","RO-2-9757","RO-29757"],"crossReferences":{"DailyMed":["fluorouracil"],"PubChem":["104171158","11111190","124880118","124880121","144203701","144209533","144210432","170464762","17389875","174007005","26747342","26752979","50105574","8139872","82653","85231050","90341469"],"Wikipedia":["Fluorouracil"],"drugbank":["DB00544"],"chEBI":["46345"]},"count":87,"approvedIndications":["EFO_0000616","EFO_0000311"],"linkedTargets":{"rows":["ENSG00000176890"],"count":1},"linkedDiseases":{"rows":["EFO_1000910","EFO_0004190","EFO_0000365","EFO_0003859","EFO_0000756","EFO_0000681","EFO_0005952","EFO_1001129","MONDO_0044704","EFO_1000984","EFO_1001951","EFO_0000178","MONDO_0002974","EFO_1000532","EFO_0008528","EFO_0004606","EFO_1000028","MONDO_0002038","EFO_0004288","EFO_1001949","EFO_0000198","EFO_0002618","EFO_0005922","EFO_0007363","EFO_0000402","EFO_0005221","MONDO_0001879","EFO_0002496","MONDO_0002691","EFO_0000546","EFO_1001365","EFO_0000678","MONDO_0000831","EFO_1000527","EFO_0004284","EFO_0000574","EFO_0001378","EFO_0000516","MONDO_0002516","EFO_0000292","EFO_0005577","EFO_0007416","MONDO_0007254","EFO_0004252","MONDO_0044937","MONDO_0020654","EFO_0003817","MONDO_0001056","MONDO_0022394","EFO_0003100","EFO_0000326","EFO_0004193","EFO_0000707","EFO_0005588","Orphanet_144","EFO_0000616","EFO_0003897","EFO_0006859","EFO_0002916","Orphanet_44890","MONDO_0007576","EFO_1001961","EFO_1001471","MONDO_0002120","EFO_0008549","EFO_0002517","EFO_0000199","MONDO_0002367","MONDO_0024880","MONDO_0024475","MONDO_0003060","EFO_0003869","EFO_1002023","EFO_1000657","EFO_0000228","MONDO_0003212","MONDO_0002358","EFO_0006732","EFO_0000182","MONDO_0003199","EFO_0000364","EFO_1000166","EFO_1000606","EFO_0000197","EFO_1000292","EFO_0000698","MONDO_0021321","MONDO_0008170","EFO_0005842","EFO_0000504","EFO_0009708","EFO_0000294","EFO_1001100","EFO_0002428","EFO_0006544","EFO_0003835","MONDO_0021355","EFO_1000172","EFO_0002938","MONDO_0004192","EFO_1001901","EFO_0003866","EFO_0005950","MONDO_0021063","MONDO_0002087","MONDO_0020657","MONDO_0001187","EFO_1001480","EFO_1000044","EFO_1000218","EFO_0003860","EFO_0004212","EFO_0000503","EFO_0000478","EFO_0000313","EFO_0003060","EFO_0000311","EFO_0005570","EFO_0010282","EFO_0004142","MONDO_0003219","EFO_1000081","EFO_0000181"],"count":123},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1962 and is indicated for neoplasm and cancer and has 85 investigational indications."}
{"id":"CHEMBL1868892","canonicalSmiles":"COCCc1ccc(OCC(O)CNC(C)C)cc1.COCCc1ccc(OCC(O)CNC(C)C)cc1.O=C(O)C(O)[C@H](O)C(=O)O","inchiKey":"YGULWPYYGQCFMP-XRDDTGOUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1868892","maximumClinicalTrialPhase":0,"parentId":"CHEMBL13","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["29216544"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1910936","canonicalSmiles":"O=C(CN1C(=O)C2(CCCC2)NC[C@H]1c1cc(F)cc(F)c1)Nc1ccc2c(c1)C[C@@]1(C2)C(=O)Nc2ncccc21","inchiKey":"AZAANWYREOQRFB-SETSBSEESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MK3207","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MK 3207","MK-3207","Mk3207"],"crossReferences":{"drugbank":["DB12424"]},"count":1,"linkedTargets":{"rows":["ENSG00000064989"],"count":1},"linkedDiseases":{"rows":["EFO_0003821"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL194859","canonicalSmiles":"O=C(c1ccc(O)cc1)c1ccc(O)cc1","inchiKey":"RXNYJUSEXLAVNQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"4,4'-Dihydroxybenzophenone","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["4,4'-Dihydroxybenzophenone","4,4-Dihydroxybenzophenone"],"crossReferences":{"PubChem":["144207748"],"Wikipedia":["4,4%27-Dihydroxybenzophenone"],"drugbank":["DB07635"],"chEBI":["34365"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1967878","canonicalSmiles":"Cc1cc(Nc2ncc(F)c(NC3C4C=CC(C4)C3C(N)=O)n2)ccc1N1CCN(C)CC1","inchiKey":"KSOVGRCOLZZTPF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CENISERTIB","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AS 703569","AS-703569","AS703569","As-703569","As703569","Cenisertib","R 763","R-763"],"crossReferences":{"PubChem":["103904402","103904437"]},"count":2,"linkedTargets":{"rows":["ENSG00000087586","ENSG00000178999","ENSG00000105146"],"count":3},"linkedDiseases":{"rows":["EFO_0000616","EFO_0001642"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2007641","drugType":"Antibody","blackBoxWarning":true,"name":"PERTUZUMAB","yearOfFirstApproval":2012,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Omnitarg","Omnitarg Perjeta","Perjeta"],"synonyms":["Pertuzumab","RG-1273","RHUMAB 2C4","RHUMAB-2C4"],"crossReferences":{"DailyMed":["pertuzumab"],"DrugCentral":["4957"],"Wikipedia":["Pertuzumab"]},"count":22,"approvedIndications":["EFO_0000616","EFO_0003869","MONDO_0007254","EFO_0000305","EFO_0000311"],"linkedTargets":{"rows":["ENSG00000141736"],"count":1},"linkedDiseases":{"rows":["EFO_0002618","EFO_0000616","EFO_0003869","EFO_0000365","EFO_0002916","MONDO_0008170","MONDO_0007254","EFO_1000657","MONDO_0021063","MONDO_0002087","EFO_0000305","EFO_0003060","MONDO_0008315","EFO_1000984","EFO_0000311","EFO_0009708","EFO_1000307","EFO_1001951","MONDO_0001056","EFO_0000304","MONDO_0002158","EFO_1001480","EFO_0003968","EFO_0006861","MONDO_0002120"],"count":25},"description":"Antibody drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2012 and has 5 approved and 17 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL202609","canonicalSmiles":"CC[C@@H](Cc1ccc(OC)c(CNC(=O)c2ccc(C(F)(F)F)cc2F)c1)C(=O)O","inchiKey":"BDLLIPYDNFENMY-ZDUSSCGKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL202609","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07070"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2103778","canonicalSmiles":"Cc1nccn1C[C@H]1CCc2c(c3cccc4c3n2CCC4)C1=O","inchiKey":"NCNFDKWULDWJDS-OAHLLOKOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CILANSETRON","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cilansetron","KC-9946"],"crossReferences":{"drugbank":["DB04885"]},"childChemblIds":["CHEMBL2107807"],"count":1,"linkedTargets":{"rows":["ENSG00000149305","ENSG00000166736"],"count":2},"linkedDiseases":{"rows":["EFO_0010282"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2104116","canonicalSmiles":"CC(CC(C)(C)O)OC(O)C(Cl)(Cl)Cl","inchiKey":"QVFWZNCVPCJQOP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHLORHEXADOL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Lora"],"synonyms":["Chloralodol","Chlorhexadol"],"crossReferences":{"drugbank":["DB01534"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2104136","canonicalSmiles":"CN(C)CCCC1c2ccccc2Nc2ccc(Cl)cc21.O=P(O)(O)O","inchiKey":"SKKDWRIEPIZVOR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CLOMACRAN PHOSPHATE","maximumClinicalTrialPhase":4,"parentId":"CHEMBL1615350","hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United Kingdom"],"classes":["Hepatotoxicity"],"year":1982},"tradeNames":["Devryl","Olaxin"],"synonyms":["Clomacran phosphate","SK&F 14336"],"description":"Small molecule drug with a maximum clinical trial phase of IV. It was withdrawn in United Kingdom  in 1982 due to Hepatotoxicity."}
{"id":"CHEMBL2104688","canonicalSmiles":"CCCN(CCC)C(=O)C(Cc1ccc(OCCN(CC)CC)cc1)NC(=O)c1ccccc1","inchiKey":"FDBWMYOFXWMGEY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TIROPRAMIDE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Tiropramide"],"crossReferences":{"drugbank":["DB13091"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL2104987","canonicalSmiles":"CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@@H](N)Cc1c[nH]cn1)[C@@H](C)O)[C@@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)[C@@H](C)O)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)CC","inchiKey":"CILIXQOJUNDIDU-ASQIGDHWSA-N","drugType":"Protein","blackBoxWarning":false,"name":"TEDUGLUTIDE","yearOfFirstApproval":2012,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Gattex kit"],"synonyms":["ALX 0600","ALX-0600","Teduglutide","Teduglutide recombinant"],"crossReferences":{"chEBI":["72305"]},"count":9,"approvedIndications":["MONDO_0015183","Orphanet_365563"],"linkedTargets":{"rows":["ENSG00000065325"],"count":1},"linkedDiseases":{"rows":["MONDO_0013730","EFO_0003086","EFO_0008572","EFO_0000764","EFO_0001421","MONDO_0015183","EFO_0003774","EFO_0000384"],"count":8},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2012 and is indicated for primary short bowel syndrome and short bowel syndrome and has 7 investigational indications."}
{"id":"CHEMBL2105456","canonicalSmiles":"CCCCC(C(=O)O)C(=O)N(Nc1ccccc1)c1ccccc1","inchiKey":"FLWFHHFTIRLFPV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BUMADIZONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bumadizone"],"crossReferences":{"drugbank":["DB13286"],"chEBI":["76119"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2105497","canonicalSmiles":"COC(CN1CCN(CC(O)C(OC)c2ccccc2)CC1)c1ccccc1","inchiKey":"VSTNNAYSCJQCQI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ZIPEPROL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Zipeprol"],"crossReferences":{"drugbank":["DB13564"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2105505","canonicalSmiles":"Cc1ccccc1C(O)(c1ccccc1C)C1CN2CCC1CC2","inchiKey":"OXDOWGVJMITMJL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SEQUIFENADINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Sequifenadine"],"crossReferences":{"drugbank":["DB13566"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2105890","canonicalSmiles":"CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C(C)C)[C@H]2O)[C@@]2(C)CC(C)=C(O2)[C@H](C)C(=O)[C@]1(C)OC.O=C(O)/C=C/C(=O)O","inchiKey":"IDLXWTNPDREJQZ-HSOMBQIOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MITEMCINAL FUMARATE","maximumClinicalTrialPhase":2,"parentId":"CHEMBL2110756","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["115-8543 JAPAN","115-8543-JAPAN","5-1 UKIMA 5 CHOME","5-1-UKIMA-5-CHOME","GM-611","KITA-KU TOYKO","Mitemcinal fumarate"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2105983","canonicalSmiles":"Nc1ccc(C(=O)[O-])c(O)c1.Nc1ccc(C(=O)[O-])c(O)c1.[Ca+2]","inchiKey":"XDWVNCOPMIEDJK-UHFFFAOYSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"AMINOSALICYLATE CALCIUM","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1169","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Aminosalicylate calcium","Calcium aminosalicylate","Calcium para-aminosalicylate"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2106499","canonicalSmiles":"CC(C)[C@H](N)C(=O)O[C@@H]1C[C@@H](n2ccc(N)nc2=O)O[C@H]1CO","inchiKey":"VFCYZPOEGWLYRM-QCZKYFFMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VALTORCITABINE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Valtorcitabine","Valtorcitabine dihydrochloride"],"crossReferences":{"drugbank":["DB06187"]},"childChemblIds":["CHEMBL2107810"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2106763","canonicalSmiles":"C=C1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO","inchiKey":"YVHXHNGGPURVOS-SBTDHBFYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FLUPREDNIDENE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Fluprednidene"],"crossReferences":{"drugbank":["DB08970"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2107383","canonicalSmiles":"COc1ccc(CCO[C@@H]2CCCC[C@H]2N2CC[C@@H](O)C2)cc1OC.Cl","inchiKey":"JMHYCBFEEFHTMK-IIUXMCBISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VERNAKALANT HYDROCHLORIDE","maximumClinicalTrialPhase":3,"parentId":"CHEMBL2111112","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["RSD-1235","RSD1235","Vernakalant hydrochloride"],"count":2,"linkedTargets":{"rows":["ENSG00000183873","ENSG00000055118","ENSG00000162989","ENSG00000130037","ENSG00000120457","ENSG00000171385"],"count":6},"linkedDiseases":{"rows":["EFO_0003911","EFO_0000275"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2107525","canonicalSmiles":"O=[32P]([O-])([O-])O.[Na+].[Na+]","inchiKey":"BNIILDVGGAEEIG-JCIGTKTHSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"SODIUM PHOSPHATE P 32","yearOfFirstApproval":1957,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1060","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Phosphotope","Sodium phosphate p 32"],"synonyms":["32p","Sodium phosphate (32p)","Sodium phosphate p 32","Sodium phosphate p-32"],"crossReferences":{"DrugCentral":["5036"],"drugbank":["DB09370"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1957."}
{"id":"CHEMBL2107841","drugType":"Protein","blackBoxWarning":true,"name":"ALBIGLUTIDE","yearOfFirstApproval":2014,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Eperzan"],"synonyms":["Albiglutide","Albiglutide (genetical recombination)","GSK-716155","GSK716155"],"count":4,"approvedIndications":["EFO_0001360","EFO_0000400"],"linkedTargets":{"rows":["ENSG00000112164"],"count":1},"linkedDiseases":{"rows":["EFO_0001359","EFO_0000373","EFO_0001360","EFO_0000400"],"count":4},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2014 and is indicated for type ii diabetes mellitus and diabetes mellitus and has 2 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL2108442","drugType":"Antibody","blackBoxWarning":false,"name":"MITUMOMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BEC2","Mitumomab"],"count":2,"description":"Antibody drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2108653","drugType":"Protein","blackBoxWarning":false,"name":"THROMBOMODULIN ALFA","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Recomodulin (japan only)"],"synonyms":["ART-123","Thrombomodulin alfa","Thrombomodulin alfa (genetical recombination)"],"count":2,"description":"Protein drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2108673","drugType":"Antibody","blackBoxWarning":false,"name":"VORSETUZUMAB","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Sgn-70, h1f6"],"synonyms":["Vorsetuzumab"],"description":"Antibody drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2108742","drugType":"Antibody","blackBoxWarning":false,"name":"SIPLIZUMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MEDI-507","Siplizumab"],"count":7,"linkedTargets":{"rows":["ENSG00000116824"],"count":1},"linkedDiseases":{"rows":["EFO_0000565","MONDO_0013730","EFO_0003086","Orphanet_238510","EFO_0003884","EFO_0000676","EFO_0000574"],"count":7},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 7 investigational indications."}
{"id":"CHEMBL2109364","drugType":"Antibody","blackBoxWarning":false,"name":"AR-20.5","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AR-20.5"],"description":"Antibody drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL2109522","drugType":"Antibody","blackBoxWarning":false,"name":"PF-03446879","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["PF-03446879"],"description":"Antibody drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2109598","drugType":"Antibody","blackBoxWarning":false,"name":"BIIB-023","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BIIB-023","Biib-023"],"count":2,"linkedTargets":{"rows":["ENSG00000239697"],"count":1},"linkedDiseases":{"rows":["EFO_0000685","EFO_0005761"],"count":2},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2110372","canonicalSmiles":"CNC(=C[N+](=O)[O-])NCCSCc1ccc(CN(C)C)o1.Cl","inchiKey":"GGWBHVILAJZWKJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RANITIDINE HYDROCHLORIDE","yearOfFirstApproval":1983,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1790041","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Azantac","Dumoran","Gavilast","Gavilast-p","Histac","Raciran 150","Raciran 300","Ranicalm","Raniplex","Ranitic","Ranitidine hydrochloride","Ranitil","Rantec","Ranzac","Vivatak","Zaedoc 150","Zaedoc 300","Zantac","Zantac 150","Zantac 25","Zantac 300","Zantac 75","Zantac 75 dissolve","Zantac 75 relief","Zantac 75 relief dissolve"],"synonyms":["AH 19065","AH-19065","Ranitidine hydrochloride"],"crossReferences":{"DailyMed":["ranitidine%20hydrochloride"]},"count":1,"linkedTargets":{"rows":["ENSG00000113749"],"count":1},"linkedDiseases":{"rows":["EFO_0000764"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1983 and has 1 investigational indication."}
{"id":"CHEMBL2110577","canonicalSmiles":"CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2OC(C)=O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O","inchiKey":"CVBHEIRZLPKMSH-SNWVVRALSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ERYTHROMYCIN ACISTRATE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Erasis"],"synonyms":["Erythromycin","Erythromycin acistrate"],"childChemblIds":["CHEMBL1908310"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL211538","canonicalSmiles":"OB1OCc2cc(Cl)ccc21","inchiKey":"HMAFTPZYFJFEHK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AN-2718","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["An-2718","An2718"],"crossReferences":{"drugbank":["DB12810"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL220492","canonicalSmiles":"CC1(C)O[C@@H]2CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@H]3[C@@H]2O1","inchiKey":"KJADKKWYZYXHBB-XBWDGYHZSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"TOPIRAMATE","yearOfFirstApproval":1996,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Epitomax","Qudexy xr","Topamax","Topamax sprinkle","Topiramate","Trokendi xr"],"synonyms":["MCN-4853","RWJ-17021","RWJ-17021-000","Topiramate","USL-255","USL255"],"crossReferences":{"DailyMed":["topiramate"],"PubChem":["144205025","144212718","170464746"],"Wikipedia":["Topiramate"],"drugbank":["DB00273"],"chEBI":["63631"]},"count":38,"approvedIndications":["EFO_0000474","EFO_0003821"],"linkedTargets":{"rows":["ENSG00000125675","ENSG00000167434","ENSG00000145863","ENSG00000011677","ENSG00000187730","ENSG00000151834","ENSG00000145864","ENSG00000149403","ENSG00000152578","ENSG00000007314","ENSG00000196876","ENSG00000022355","ENSG00000185313","ENSG00000183873","ENSG00000104267","ENSG00000155511","ENSG00000186297","ENSG00000163288","ENSG00000153253","ENSG00000136546","ENSG00000120251","ENSG00000109158","ENSG00000168356","ENSG00000166206","ENSG00000163873","ENSG00000182256","ENSG00000102287","ENSG00000164418","ENSG00000144285","ENSG00000171189","ENSG00000094755","ENSG00000268089","ENSG00000113327","ENSG00000169432","ENSG00000163285","ENSG00000105737","ENSG00000136531"],"count":37},"linkedDiseases":{"rows":["EFO_0005204","EFO_0002610","HP_0000726","HP_0001268","EFO_0003768","EFO_0003774","EFO_1001917","HP_0011868","EFO_0003829","EFO_0005924","EFO_0007191","EFO_0004211","MONDO_0002046","HP_0100543","EFO_0000474","Orphanet_739","EFO_0000289","MONDO_0002050","EFO_0004263","MONDO_0005299","EFO_1000632","HP_0002013","EFO_0004701","EFO_0004242","EFO_0005230","EFO_0000692","EFO_0000400","EFO_0004319","EFO_0005203","EFO_0004329","EFO_0003821","EFO_0002508","EFO_0005207","EFO_0001358","HP_0001250","Orphanet_2382","EFO_0010445","EFO_0001073","EFO_0003843","HP_0002315","EFO_0000537","EFO_0000195","EFO_0003885","EFO_0004895","EFO_0001421","EFO_0004699","EFO_0000516","EFO_0004270","EFO_0001360","EFO_0007262","EFO_0003108"],"count":51},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1996 and is indicated for epilepsy and migraine disorder and has 36 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL2218908","canonicalSmiles":"CC(C)CCCCC(=O)N[C@@H](CCN)C(=O)N[C@@H](CN[C@@H](CCN)C(=O)N[C@H]1CCNC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CCN)NC1=O)[C@@H](C)O.CCC(C)CCCCC(=O)N[C@@H](CCN)C(=O)N[C@@H](CN[C@@H](CCN)C(=O)N[C@H]1CCNC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CCN)NC1=O)[C@@H](C)O.O=S(=O)(O)O.O=S(=O)(O)O","inchiKey":"ZESIAEVDVPWEKB-ORCFLVBFSA-N","drugType":"Protein","blackBoxWarning":false,"name":"COLISTIN SULFATE","yearOfFirstApproval":1962,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL2221249","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cantrex","Coly-mycin","Coly-mycin s","Kanamycin","Kanamycin Sulfate","Kannasyn","Kantrex","Kantrim","Klebcil"],"synonyms":["Colistin sulfate","Colistin sulphate"],"description":"Protein drug with a maximum clinical trial phase of IV that was first approved in 1962."}
{"id":"CHEMBL2218922","canonicalSmiles":"CN1CCC23NC(=O)CC(c4cc(Cl)ccc4O2)C3C1","inchiKey":"MJRPHRMGEKCADU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LORTALAMINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["LM-1404","Lortalamine"],"crossReferences":{"drugbank":["DB09187"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2219410","canonicalSmiles":"O=C([O-])c1ccc(/C=C/S(=O)(=O)Cc2ccc(Cl)cc2)cc1.[Na+]","inchiKey":"PRFBWBYKWZVQJF-RRABGKBLSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"RECILISIB SODIUM","maximumClinicalTrialPhase":0,"parentId":"CHEMBL2219421","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Ex-rad"],"synonyms":["ON 01210. Na","Recilisib sodium"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL227439","canonicalSmiles":"O=C(COc1ccc(Cl)cc1)Nc1ccccc1C(=O)O","inchiKey":"LXSDGQYDSDIUPN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL227439","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07185"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL228077","canonicalSmiles":"NC(=O)[C@@H]1C[C@@H](NC(=O)[C@@H](N)CCC/N=C(\\N)N[N+](=O)[O-])CN1","inchiKey":"IUFRDGFKAVLPFZ-CSMHCCOUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL228077","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02077"]},"childChemblIds":["CHEMBL161297"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2287680","canonicalSmiles":"O=C(NC(=O)c1c(F)cccc1F)Nc1ccc(Oc2ccc(C(F)(F)F)cc2Cl)cc1F","inchiKey":"RYLHNOVXKPXDIP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FLUFENOXURON","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144211081"],"drugbank":["DB15006"],"chEBI":["39382"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL233349","canonicalSmiles":"N=C1NC(=O)/C(=C/c2ccc(-c3ccc(C(=O)O)cc3)o2)S1","inchiKey":"JLRKRQCTYQGDKJ-GHXNOFRVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL233349","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07539"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2366023","canonicalSmiles":"CCCCCCCC[N+](C)(C)CCCCCCCC","inchiKey":"MELGLHXCBHKVJG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL2366023","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["225144332"],"drugbank":["DB13970"]},"childChemblIds":["CHEMBL2357351"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2375161","canonicalSmiles":"CCCCCc1ccc(/C(C)=C/C(=O)N[C@H](Cc2c[nH]c3ccccc23)C(=O)N[C@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]2C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c3ccccc3N)C(=O)O[C@@H]2C)cc1","inchiKey":"DYNMYYRPPFVAKR-ZXTAUSOFSA-N","drugType":"Protein","blackBoxWarning":false,"name":"SUROTOMYCIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Cb-183, 315"],"synonyms":["CB-183,315","CB-183315","Surotomycin"],"count":1,"description":"Protein drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL25","canonicalSmiles":"CC(=O)Oc1ccccc1C(=O)O","inchiKey":"BSYNRYMUTXBXSQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ASPIRIN","yearOfFirstApproval":1950,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["8-hour bayer","Acetosalic Acid","Acetylsalic acid","Acetylsalicylic Acid","Alka rapid","Anadin all night","Angettes 75","Aspirin","Aspro clr","Bayer extra strength aspirin for migraine pain","Danamep","Disprin cv","Disprin direct","Durlaza","Ecotrin","Enprin","Equi-Prin","Gencardia","Levius","Max strgh aspro clr","Measurin","Micropirin ec","Nu-seals 300","Nu-seals 600","Nu-seals 75","Nu-seals cardio 75","Paynocil","Platet","Platet 300","Postmi 300","Postmi 75","Salicylic Acid Acetate","Vazalore"],"synonyms":["Acetylsalicylic Acid","Acetylsalicylic acid","Aspirin","BAY1019036","NSC-27223","NSC-406186"],"crossReferences":{"DailyMed":["aspirin"],"PubChem":["144203627","144209315","144210466","170465039","17389202","17390036","174007205","26747283","26752858","47193676","50105490","85230910","87798","90340586"],"TG-GATEs":["14"],"Wikipedia":["Aspirin"],"drugbank":["DB00945"],"chEBI":["15365"]},"childChemblIds":["CHEMBL1697753","CHEMBL2296002"],"count":131,"approvedIndications":["MONDO_0000831","EFO_0003821","EFO_0000712","HP_0001945","HP_0004419","EFO_0003843"],"linkedTargets":{"rows":["ENSG00000073756","ENSG00000095303"],"count":2},"linkedDiseases":{"rows":["Orphanet_64739","EFO_0001361","EFO_0000275","EFO_0000401","EFO_0003768","EFO_0003762","HP_0012228","EFO_0004698","EFO_1001923","EFO_1001951","EFO_0003914","EFO_0003931","EFO_0000339","EFO_0008585","EFO_0002690","MONDO_0002974","EFO_0009573","EFO_0005306","EFO_0003884","EFO_1000882","EFO_0000400","EFO_1000059","MONDO_0002635","EFO_0009686","HP_0005521","EFO_0000180","EFO_0004286","EFO_0007443","EFO_0004607","MONDO_0008315","EFO_0001663","EFO_1002022","EFO_0000546","GO_0007568","MP_0001914","MONDO_0000831","EFO_0003907","EFO_0007328","EFO_0001378","EFO_0000341","MONDO_0002258","EFO_1000860","EFO_0005672","EFO_0004610","MONDO_0021108","MONDO_0007254","MONDO_0043839","EFO_0004252","EFO_1000637","EFO_0000495","EFO_0009606","MONDO_0001056","EFO_0000289","EFO_0009854","EFO_1001161","HP_0004419","EFO_0003763","EFO_0000707","Orphanet_144","EFO_0000616","EFO_0000694","EFO_0000280","EFO_0006859","HP_0020174","EFO_0001645","EFO_0009463","EFO_0003929","MONDO_0007576","GO_0070527","EFO_0000319","EFO_1001157","EFO_0009315","EFO_0005407","EFO_0003843","HP_0002315","EFO_0000537","EFO_1000954","EFO_0000195","EFO_1000881","EFO_0009454","MONDO_0010888","MONDO_0021661","EFO_0000649","EFO_0000764","MONDO_0011962","EFO_0009314","EFO_0005411","EFO_0000519","EFO_0004265","EFO_0004264","EFO_0008493","EFO_0000729","EFO_0003869","EFO_0003777","HP_0002745","HP_0002239","MONDO_0002009","EFO_0000571","EFO_0005406","EFO_1001154","EFO_1000657","EFO_0000266","MONDO_0000527","EFO_0003913","EFO_0002506","EFO_0003870","Orphanet_733","EFO_0000389","EFO_0000182","EFO_0006510","HP_0003419","EFO_0007541","HP_0012378","EFO_0000692","EFO_0003893","HP_0003124","EFO_0003821","MONDO_0008170","Orphanet_3389","EFO_0002429","Orphanet_309005","EFO_0000294","HP_0100806","MP_0001845","MONDO_0100096","EFO_0000270","EFO_0001359","EFO_0001360","EFO_0000668","EFO_0001059","Orphanet_232","MONDO_0002679","MONDO_0021063","EFO_0000538","EFO_0002950","EFO_0004246","HP_0004398","EFO_0004211","EFO_1001375","EFO_0003144","EFO_0000712","MONDO_0004247","EFO_0000673","HP_0000618","EFO_0007427","EFO_0007129","EFO_0000717","HP_0004936","EFO_0008586","EFO_0000479","HP_0002140","EFO_0000545","EFO_0003875","HP_0001945","HP_0001655","EFO_0000556","EFO_0003770","EFO_0004277","EFO_0003060","EFO_0007214","EFO_0002615","EFO_0000311","EFO_0003106","EFO_0010282","EFO_0003764","EFO_0008583","EFO_0000612","EFO_0004259"],"count":168},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1950 and has 6 approved and 125 investigational indications."}
{"id":"CHEMBL264374","canonicalSmiles":"CC(C)(Oc1ccc(CCNC(=O)c2ccc(Cl)cc2)cc1)C(=O)O","inchiKey":"IIBYAHWJQTYFKB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BEZAFIBRATE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Bezagen xl","Bezalip","Bezalip-mono","Fibrazate xl","Liparol xl","Zimbacol xl"],"synonyms":["BM 15.075","BM-15.075","BM-15075","Bezafibrate"],"crossReferences":{"PubChem":["11112764","144204196","144212162","170465743","26751546","26751547","56422496","855877","90341401"],"Wikipedia":["Bezafibrate"],"drugbank":["DB01393"],"chEBI":["47612"]},"count":7,"approvedIndications":["EFO_0000319"],"linkedTargets":{"rows":["ENSG00000112033","ENSG00000186951","ENSG00000132170"],"count":3},"linkedDiseases":{"rows":["Orphanet_68380","EFO_0004268","EFO_0000289","Orphanet_79211","EFO_0008583","EFO_0000319","EFO_0001360","EFO_1001486","Orphanet_157"],"count":9},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for cardiovascular disease and has 6 investigational indications."}
{"id":"CHEMBL284642","canonicalSmiles":"Cc1c[nH]c2c(O)cc3c(c12)[C@H](CCl)CN3C(=O)c1cc2cc(NC(=O)Nc3ccc4[nH]c(C(=O)N5C[C@@H](CCl)c6c5cc(O)c5[nH]cc(C)c65)cc4c3)ccc2[nH]1","inchiKey":"FONKWHRXTPJODV-DNQXCXABSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BIZELESIN","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bizelesin","U 77779","U-77779"],"crossReferences":{"PubChem":["487336"],"drugbank":["DB12352"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL284906","canonicalSmiles":"O=C(NCCO[N+](=O)[O-])c1cccnc1","inchiKey":"LBHIOVVIQHSOQN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NICORANDIL","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ikorel"],"synonyms":["Nicorandil","SG-75"],"crossReferences":{"PubChem":["11114278","144204519","170465582","26719873","85148372"],"Wikipedia":["Nicorandil"],"drugbank":["DB09220"],"chEBI":["31905"]},"count":4,"approvedIndications":["EFO_0000319"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for cardiovascular disease and has 3 investigational indications."}
{"id":"CHEMBL29","canonicalSmiles":"CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O","inchiKey":"JGSARLDLIJGVTE-MBNYWOFBSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"BENZYLPENICILLIN","yearOfFirstApproval":1947,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Crystapen g"],"synonyms":["Benzylpenicillin","Benzylpenicillin ","Bicillin","J01CE01","NSC-193396","Penicillin G","Penicillin g","Penicillin-2","Permapen","Pfizerpen-AS"],"crossReferences":{"DailyMed":["penicillin%20g%20benzathine","penicillin%20g%20potassium","penicillin%20g%20sodium"],"PubChem":["49647119"],"Wikipedia":["Benzylpenicillin"],"drugbank":["DB01053"],"chEBI":["18208"]},"childChemblIds":["CHEMBL2105364","CHEMBL2107679","CHEMBL3989515","CHEMBL3182097","CHEMBL1126","CHEMBL1200651","CHEMBL1223"],"count":6,"approvedIndications":["EFO_0000771","EFO_1001888"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1947 and is indicated for eye infection and bacterial disease and has 4 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL3092995","canonicalSmiles":"NS(=O)(=O)NC[C@H]1COc2cc(Cl)ccc2O1","inchiKey":"KXSAIQPPGSSNKX-ZETCQYMHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"JNJ-26489112","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["JNJ-26489112","Jnj-26489112"],"crossReferences":{"drugbank":["DB15203"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL318191","canonicalSmiles":"CC(=O)c1ccc2c(c1)[C@H](NC(=O)c1ccc(F)c(Cl)c1)[C@H](O)C(C)(C)O2","inchiKey":"XLIIRNOPGJTBJD-ROUUACIJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TONABERSAT","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["SB-220453","Tonabersat"],"crossReferences":{"drugbank":["DB06578"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3184383","canonicalSmiles":"COc1ccc(C[C@@H](C)NC[C@H](O)c2ccc(O)c(NC=O)c2)cc1.COc1ccc(C[C@@H](C)NC[C@H](O)c2ccc(O)c(NC=O)c2)cc1.O=C(O)/C=C/C(=O)O","inchiKey":"OBRNDARFFFHCGE-QDSVTUBZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3184383","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1363","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144206287"],"chEBI":["63108"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3350765","canonicalSmiles":"[2H]C([2H])(N)C(=O)CCC(=O)O","inchiKey":"ZGXJTSGNIOSYLO-SMZGMGDZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3350765","maximumClinicalTrialPhase":0,"parentId":"CHEMBL601","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3393066","canonicalSmiles":"Cc1nc2c(-c3cnc(N)nc3)nc(N3CCOCC3)nc2n1C(C)C","inchiKey":"QYBGBLQCOOISAR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3393066","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB12986"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3402567","canonicalSmiles":"COc1c(NC(=O)C(=O)c2ccc(OCCN3CCOCC3)c3ccccc23)cc(C(C)(C)C)cc1NS(C)(=O)=O.Cl","inchiKey":"ICIJBYYMEBOTQP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ITX-5061","maximumClinicalTrialPhase":1,"parentId":"CHEMBL1208829","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ITX 5061","Itx 5061","Itx-5061"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3544964","canonicalSmiles":"Cn1nccc1Nc1nccc(-c2ccn([C@H](CO)c3ccc(Cl)c(F)c3)c(=O)c2)n1","inchiKey":"RZUOCXOYPYGSKL-GOSISDBHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RAVOXERTINIB","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GDC-0994","GDC0994","Gdc-0994","RG-7842","Ravoxertinib"],"crossReferences":{"drugbank":["DB15281"]},"childChemblIds":["CHEMBL4581802"],"count":1,"linkedTargets":{"rows":["ENSG00000102882","ENSG00000100030"],"count":2},"linkedDiseases":{"rows":["EFO_0000616"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3545026","drugType":"Small molecule","blackBoxWarning":false,"name":"FAMITINIB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Famitinib","SHR1020","Shr-1020"],"count":10,"linkedTargets":{"rows":["ENSG00000134853","ENSG00000128052","ENSG00000102755","ENSG00000037280","ENSG00000157404","ENSG00000113721","ENSG00000122025"],"count":7},"linkedDiseases":{"rows":["EFO_0000616","EFO_0003869","EFO_1001480","EFO_0000365","MONDO_0024503","EFO_0000681","EFO_0005537","Orphanet_44890","EFO_0004252","EFO_0003060","EFO_0000311"],"count":11},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 10 investigational indications."}
{"id":"CHEMBL3545157","canonicalSmiles":"O=c1sn(-c2cccc3ccccc23)c(=O)n1Cc1ccccc1","inchiKey":"PMJIHLSCWIDGMD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TIDEGLUSIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Zentylor nypta"],"synonyms":["NP-031112","NP-12","NP031112","Np-031112","Tideglusib"],"crossReferences":{"drugbank":["DB12129"]},"count":3,"linkedTargets":{"rows":["ENSG00000082701"],"count":1},"linkedDiseases":{"rows":["EFO_0003756","Orphanet_206647","EFO_0000249"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL3545311","canonicalSmiles":"COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2P(C)(C)=O)n1","inchiKey":"AILRADAXUVEEIR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BRIGATINIB","yearOfFirstApproval":2017,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Alunbrig"],"synonyms":["AP-26113","AP26113","Ap-26113","Brigatinib"],"crossReferences":{"DailyMed":["brigatinib"],"drugbank":["DB12267"]},"count":4,"approvedIndications":["EFO_0000616","EFO_0003060","EFO_0000311"],"linkedTargets":{"rows":["ENSG00000146648","ENSG00000171094"],"count":2},"linkedDiseases":{"rows":["EFO_0000616","EFO_0003032","MONDO_0024880","EFO_0003060","EFO_0000311"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2017 and has 3 approved and 1 investigational indication."}
{"id":"CHEMBL3577885","canonicalSmiles":"C[C@H](c1ccc(F)cc1)N(Cc1cccc(C(=O)O)c1)C(=O)c1cnc2ccccc2c1","inchiKey":"BXNMZRPTQFVRFA-QGZVFWFLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PF-05105679","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["PF 5105679","Pf-05105679"],"crossReferences":{"drugbank":["DB15450"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3707253","drugType":"Antibody","blackBoxWarning":false,"name":"BEVACIZUMAB 111IN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bevacizumab 111in","Bevacizumab in111"],"description":"Antibody drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3786673","canonicalSmiles":"CC/C=C\\C/C=C\\C/C=C\\C/C=C\\C/C=C\\C/C=C\\CCC(=O)NCCNC(=O)c1ccccc1O","inchiKey":"JQLBBYLGWHUHRW-KUBAVDMBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"EDASALONEXENT","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CAT 1004","Cat 1004","Cat-1004","Edasalonexent"],"crossReferences":{"drugbank":["DB15010"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3833391","canonicalSmiles":"CCCCC1C(=O)N(C)N(C)C1=O.CCN(CC)CCNC(=O)COc1ccc(Cl)cc1.O.O","inchiKey":"JNHZIFUHHHJTFM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CLOFEZONE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL3833413","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ANP 3260","Clofezone"],"crossReferences":{"DrugCentral":["4335"]},"count":3,"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL3833402","canonicalSmiles":"O=S(=O)([O-])[O-].O=S(=O)([O-])[O-].O=S(=O)([O-])[O-].[Al+3].[Al+3]","inchiKey":"DIZPMCHEQGEION-UHFFFAOYSA-H","drugType":"Small molecule","blackBoxWarning":false,"name":"ALUMINUM SULFATE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Aluminum sulfate"],"crossReferences":{"drugbank":["DB11239"]},"childChemblIds":["CHEMBL3833332"],"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL395336","canonicalSmiles":"Nc1nc2c(ncn2[C@@H]2O[C@@H]3COP(=O)(O)O[C@H]3[C@H]2O)c(=O)[nH]1","inchiKey":"ZOOGRGPOEVQQDX-UUOKFMHZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"cyclic GMP","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["cyclic GMP"],"crossReferences":{"Wikipedia":["Cyclic_guanosine_monophosphate"],"drugbank":["DB02315"],"chEBI":["16356"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3961431","canonicalSmiles":"O=C([O-])COC[C@H]1CC[C@H](COC(=O)N(c2ccccc2)c2ccc(Cl)cc2)CC1.[Na+]","inchiKey":"KDQFEGDAYHKNDI-YHSIFKNPSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3961431","maximumClinicalTrialPhase":0,"parentId":"CHEMBL3301604","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3979920","canonicalSmiles":"Cn1cc(-c2nc(N[C@@H]3CCCC[C@@H]3N)c(F)c3c2C(=O)NC3)cn1","inchiKey":"MJHOMTRKVMKCNE-NWDGAFQWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MIVAVOTINIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Mivavotinib","TAK-659F"],"childChemblIds":["CHEMBL4594253"],"linkedTargets":{"rows":["ENSG00000165025"],"count":1},"linkedDiseases":{"rows":["MONDO_0044889","EFO_0001075","EFO_0000403","EFO_0000574","EFO_0000222","MONDO_0018906","EFO_0005952"],"count":7},"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL3989426","drugType":"Small molecule","blackBoxWarning":false,"name":"CALAMINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cala soothe","Christie george's","Eczederm"],"synonyms":["Calamine"],"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL3989573","canonicalSmiles":"CN1C(=O)CC[C@H]1c1cccnc1.CN1C(=O)CC[C@H]1c1cccnc1.O=C(O)/C=C/C(=O)O","inchiKey":"NXHGVNVRWLOZDF-SZYUIZJOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"COTININE FUMARATE","maximumClinicalTrialPhase":2,"parentId":"CHEMBL578211","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cotinine fumarate"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3989893","canonicalSmiles":"CNc1ccc(C(=O)CC(O)CCC(C)C2OC(=O)CC(O)CC(=O)CC(O)CC(O)CC(O)CC(O)CC3(O)CC(O)C(C(=O)OC)C(CC(O[C@@H]4O[C@H](C)[C@@H](O)[C@H](N)[C@@H]4O)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/C2C)O3)cc1.COC(=O)C1C(O)CC2(O)CC(O)CC(O)CC(O)CC(O)CC(=O)CC(O)CC(=O)OC(C(C)CCC(O)CC(=O)c3ccc(N)cc3)C(C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/C(O[C@@H]3O[C@H](C)[C@@H](O)[C@H](N)[C@@H]3O)CC1O2","inchiKey":"ALPPGSBMHVCELA-WHUUVLPESA-N","drugType":"Unknown","blackBoxWarning":false,"name":"MEPARTRICIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Mepartricin","SN 654","SPA-S-160"],"count":2,"description":"Unknown drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3989950","canonicalSmiles":"CSCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CO)NC(=O)[C@@H](C)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)O)C(C)C","inchiKey":"VRNHFZYMPDKTBS-WYUJEMNCSA-N","drugType":"Protein","blackBoxWarning":false,"name":"RELTECIMOD","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AB103","Reltecimod"],"childChemblIds":["CHEMBL3989963"],"count":1,"description":"Protein drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL402548","canonicalSmiles":"CO[C@@H](C(=O)N1Cc2n[nH]c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1","inchiKey":"XKFTZKGMDDZMJI-HSZRJFAPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DANUSERTIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Danusertib","PHA-739358","Pha-739358"],"crossReferences":{"drugbank":["DB11778"]},"childChemblIds":["CHEMBL534499"],"count":3,"linkedTargets":{"rows":["ENSG00000087586","ENSG00000178999","ENSG00000105146"],"count":3},"linkedDiseases":{"rows":["EFO_0000565","EFO_0001378","MONDO_0008315"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL405","canonicalSmiles":"CC(N)Cc1ccccc1","inchiKey":"KWTSXDURSIMDCE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"AMPHETAMINE","yearOfFirstApproval":1955,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Adzenys er","Adzenys xr-odt","Dyanavel xr"],"synonyms":["Amfetamine","Amphetamine","Amphetamine resin complex","NSC-27159"],"crossReferences":{"DailyMed":["amphetamine","amphetamine%20aspartate","amphetamine%20sulfate"],"Wikipedia":["Adderall","Amphetamine"],"drugbank":["DB00182"],"chEBI":["2679"]},"childChemblIds":["CHEMBL3250774","CHEMBL1200377","CHEMBL3250773","CHEMBL3250775","CHEMBL554211","CHEMBL1200387","CHEMBL3250772","CHEMBL3250770","CHEMBL3250771","CHEMBL501"],"count":2,"approvedIndications":["EFO_0003888"],"linkedTargets":{"rows":["ENSG00000103546","ENSG00000142319"],"count":2},"linkedDiseases":{"rows":["EFO_0003888","EFO_0005203","EFO_0002610","MONDO_0002009","EFO_0010445","EFO_0000614"],"count":6},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1955 and is indicated for attention deficit hyperactivity disorder and has 1 investigational indication. This drug has a black box warning from the FDA."}
{"id":"CHEMBL4069704","canonicalSmiles":"CCOC(=O)[C@@H]1CC2(CCN(c3cc(O[C@H](c4ccc(Cl)cc4-c4ccccc4)C(F)(F)F)nc(N)n3)CC2)CN1","inchiKey":"TZSZZENYCISATO-WIOPSUGQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RODATRISTAT ETHYL","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["KAR-5585","KAR5585","Rodatristat ethyl"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4071984","canonicalSmiles":"CCS(=O)(=O)O.S=C(NCc1ccc2c(c1)OCO2)N1CCN(c2ncnc3c2oc2ccccc23)CC1","inchiKey":"CYDGDHMBOIIPSU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL4071984","maximumClinicalTrialPhase":0,"parentId":"CHEMBL2103851","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL408513","canonicalSmiles":"O=C(/C=C/c1cccc(S(=O)(=O)Nc2ccccc2)c1)NO","inchiKey":"NCNRHFGMJRPRSK-MDZDMXLPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BELINOSTAT","yearOfFirstApproval":2014,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Beleodaq"],"synonyms":["Belinostat","NSC726630","PX-105684","PXD-101","PXD101"],"crossReferences":{"DailyMed":["belinostat"],"Wikipedia":["Belinostat"],"drugbank":["DB05015"],"chEBI":["61076"]},"count":32,"approvedIndications":["EFO_0000211","EFO_0000616","EFO_0000311"],"linkedTargets":{"rows":["ENSG00000108840","ENSG00000094631","ENSG00000061273","ENSG00000147099","ENSG00000163517","ENSG00000116478","ENSG00000100429","ENSG00000068024","ENSG00000171720","ENSG00000048052","ENSG00000196591"],"count":11},"linkedDiseases":{"rows":["MONDO_0019471","EFO_0002913","EFO_1000131","MONDO_0004222","EFO_1001469","MONDO_0002087","EFO_0000228","EFO_1000357","EFO_0000309","MONDO_0002158","EFO_1000043","EFO_0000588","EFO_0000182","EFO_0000183","EFO_1001963","EFO_0000198","EFO_0000616","MONDO_0019465","EFO_0000466","EFO_0001642","MONDO_0019457","EFO_0000403","EFO_0000222","EFO_0000313","EFO_1001968","EFO_0003060","EFO_0000311","EFO_0000211","EFO_1000576","EFO_0000304","EFO_1000581","EFO_0003032","EFO_0010832","EFO_0000702","EFO_0000574","EFO_1001051","EFO_0001378","MONDO_0018906","EFO_0000519"],"count":39},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2014 and has 3 approved and 29 investigational indications."}
{"id":"CHEMBL42161","canonicalSmiles":"COCC(O)Cn1ccnc1[N+](=O)[O-]","inchiKey":"OBBCSXFCDPPXOL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MISONIDAZOLE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Misonidazole","RO 7-0582"],"crossReferences":{"PubChem":["139075","99360758"],"Wikipedia":["Misonidazole"],"drugbank":["DB11716"]},"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL4218271","canonicalSmiles":"C[C@H](N)C(=O)N1C[C@H](CCCB(O)O)[C@](N)(C(=O)O)C1","inchiKey":"ZZJLMZYUGLJBSO-LAEOZQHASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NUMIDARGISTAT","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CB-1158","Cb-1158","INCB-001158","INCB001158","Incb 001158","Incb001158","Numidargistat"],"crossReferences":{"drugbank":["DB15286"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297142","canonicalSmiles":"CC(=O)O.CC(=O)O.CCC(C)CC(C)CCCCCCCCC(=O)N[C@H]1C[C@@H](O)[C@@H](NCCN)NC(=O)[C@@H]2[C@@H](O)CCN2C(=O)[C@H]([C@H](O)CCN)NC(=O)[C@H]([C@H](O)[C@@H](O)c2ccc(O)cc2)NC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@H]([C@@H](C)O)NC1=O","inchiKey":"OGUJBRYAAJYXQP-LLXMLGLCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CASPOFUNGIN ACETATE","yearOfFirstApproval":2001,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL499808","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cancidas","Caspofungin acetate"],"synonyms":["Caspofungin acetate","MK-0991"],"crossReferences":{"DailyMed":["caspofungin%20acetate"]},"count":6,"approvedIndications":["EFO_1001282","MONDO_0002026"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2001 and is indicated for candidemia and candidiasis and has 4 investigational indications."}
{"id":"CHEMBL4297478","canonicalSmiles":"Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1nnc2ccccn12","inchiKey":"SLIVDYMORZGPLW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PF-114","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["PF-114","Pf-114"],"crossReferences":{"drugbank":["DB15396"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4297482","canonicalSmiles":"Cc1c2c(nn1C)CSCc1cc(n(C)n1)CSc1cc(c3ccccc3c1)OCCCc1c(C(=O)O)n(C)c3c-2c(Cl)ccc13","inchiKey":"KBQCEQAXHPIRTF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AZD-5991","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AZD-5991","AZD5991","Azd-5991","Azd5991"],"crossReferences":{"drugbank":["DB14792"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4297524","canonicalSmiles":"Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cnccn5)n4)c3)cc(C(F)(F)F)c2)cn1","inchiKey":"DUPWHXBITIZIKZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RADOTINIB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["IY5511","Radotinib"],"crossReferences":{"drugbank":["DB12323"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL4297787","drugType":"Antibody","blackBoxWarning":false,"name":"MONALIZUMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["IPH-2201 (ANTI-NKG2A)","IPH2201","Iph2201","Monalizumab","NN-8765","NN8765","NN8765-3658"],"count":6,"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 6 investigational indications."}
{"id":"CHEMBL4297926","drugType":"Unknown","blackBoxWarning":false,"name":"CJM-112","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CJM-112","CJM112","Cjm-112","Cjm112"],"count":5,"description":"Unknown drug with a maximum clinical trial phase of II (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL4298006","drugType":"Antibody","blackBoxWarning":false,"name":"ENVAFOLIMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Envafolimab","KN-035","KN035","Kn 035","Kn035"],"count":3,"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4298036","drugType":"Unknown","blackBoxWarning":false,"name":"CURCUMINOIDS","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Curcuminoids","Meriva","Norflo oro"],"count":2,"description":"Unknown drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4298043","canonicalSmiles":"Cl.O.O.O=C(CN1CCC(CN2Cc3ccccc3C2=O)CC1)c1ccc(F)cc1","inchiKey":"NZKANSJXJCILHS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ROLUPERIDONE HYDROCHLORIDE","maximumClinicalTrialPhase":1,"parentId":"CHEMBL4297605","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CYR-101","CYR-101 HYDROCHLORIDE DIHYDRATE","MIN-101","MT-210","Min-101","Roluperidone hydrochloride"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4298084","drugType":"Antibody","blackBoxWarning":false,"name":"ODRONEXTAMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Odronextamab","REGN-1979","REGN1979","Regn-1979","Regn1979"],"count":3,"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL433","canonicalSmiles":"CCCC(CCC)C(=O)[O-].[Na+]","inchiKey":"AEQFSUDEHCCHBT-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":true,"name":"VALPROATE SODIUM","yearOfFirstApproval":1996,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL109","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Delepsine","Depacon","Depakine","Depakote","Depakote CP","Depakote ER","Epilim","Epilim 200","Epilim 500","Epilim chrono 200","Epilim chrono 300","Epilim chrono 500","Epilim chronosphere","Epilim iv","Episenta","Kentilim","Orfiril","Orlept","Valproate sodium"],"synonyms":["A-44090","ABBOTT 44090","ABBOTT-44090","KW-6066N","Sodium valproate","Valproate sodium","Valproic acid sodium salt (1:1)"],"crossReferences":{"DailyMed":["valproate%20sodium"],"PubChem":["11112073","144212940","50106736","50112990","57264447","85231324"],"Wikipedia":["Sodium_valproate"],"chEBI":["9925"]},"count":20,"approvedIndications":["EFO_0000474"],"linkedTargets":{"rows":["ENSG00000112294"],"count":1},"linkedDiseases":{"rows":["EFO_0008526","EFO_0008525","EFO_0003888","EFO_0005762","EFO_0003821","EFO_0000249","EFO_0000403","EFO_0003758","EFO_0009963","HP_0001250","Orphanet_783","EFO_0003829","HP_0000713","Orphanet_368","EFO_0000289","EFO_0000474","EFO_0009430","EFO_0005800","EFO_0000095","EFO_0000270","EFO_0000253","EFO_0005611","MONDO_0043510","EFO_0000692","EFO_0000519","MONDO_0003478"],"count":26},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1996 and is indicated for epilepsy and has 19 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL451509","canonicalSmiles":"CCCCC/C=C\\C/C=C\\C=C\\C=C\\[C@@H](SC[C@H](NC(=O)CC[C@H](N)C(=O)O)C(=O)NCC(=O)O)[C@@H](O)CCCC(=O)O","inchiKey":"GWNVDXQDILPJIG-NXOLIXFESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL451509","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["26756768"],"drugbank":["DB08855"],"chEBI":["16978"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL453137","canonicalSmiles":"Cc1cc(C(=O)Nc2cc(Br)c(O)c(Br)c2)cc(C)c1O","inchiKey":"HHFKUQZPNITQLU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL453137","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07695"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4594554","drugType":"Antibody","blackBoxWarning":false,"name":"TAFOLECIMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["IBI-306","IBI306","Ibi306","Tafolecimab"],"count":3,"description":"Antibody drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL468837","canonicalSmiles":"CCC1(C2=CCCCCC2)C(=O)NC(=O)NC1=O","inchiKey":"PAZQYDJGLKSCSI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HEPTABARBITAL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Heptabarb","Heptabarbital"],"crossReferences":{"Wikipedia":["Heptabarb"],"drugbank":["DB01354"],"chEBI":["81297"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL47405","canonicalSmiles":"O=C(Cn1ccnc1[N+](=O)[O-])NCCO","inchiKey":"WCDWBPCFGJXFJZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ETANIDAZOLE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Radinyl"],"synonyms":["Etanidazole","SR 2508"],"crossReferences":{"PubChem":["11112677","144204150","148250","170466603","26749865"],"Wikipedia":["Etanidazole"],"drugbank":["DB12736"],"chEBI":["75473"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL475534","canonicalSmiles":"CCOC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1c1cccc([N+](=O)[O-])c1","inchiKey":"PVHUJELLJLJGLN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NITRENDIPINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Baypress"],"synonyms":["BAY E 5009","BAY-E-5009","Nitrendipine"],"crossReferences":{"PubChem":["104171193","124880808","144203752","170465897","26751794","26751795","50104488","85231144","90341570"],"Wikipedia":["Nitrendipine"],"drugbank":["DB01054"],"chEBI":["7582"]},"count":2,"approvedIndications":["EFO_0000319"],"linkedTargets":{"rows":["ENSG00000157388","ENSG00000081248","ENSG00000151067","ENSG00000102001"],"count":4},"linkedDiseases":{"rows":["EFO_0000319","EFO_0000537"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for cardiovascular disease and has 1 investigational indication."}
{"id":"CHEMBL483158","canonicalSmiles":"COc1cc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2OC)=NC3)ccc1C(=O)O","inchiKey":"ZLHFILGSQDJULK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ALISERTIB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Alisertib","MLN 8237","MLN-8237","MLN8237","Mln-8237"],"crossReferences":{"PubChem":["103905632","137276087","174006392"],"drugbank":["DB05220"]},"childChemblIds":["CHEMBL2103871","CHEMBL3586471"],"count":22,"linkedTargets":{"rows":["ENSG00000087586"],"count":1},"linkedDiseases":{"rows":["EFO_0000198","EFO_0000616","EFO_0006859","EFO_0001075","EFO_0000403","MONDO_0007254","EFO_0000222","EFO_1001469","MONDO_0002087","EFO_0000305","EFO_0003060","EFO_0000621","EFO_0000311","EFO_0000211","EFO_0000309","MONDO_0002158","EFO_1001974","MONDO_0008903","EFO_0000673","EFO_0000574","EFO_1002008","EFO_0000702","MONDO_0018906","EFO_0001378","EFO_0006544","MONDO_0002516","EFO_0000181"],"count":27},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 22 investigational indications."}
{"id":"CHEMBL484780","canonicalSmiles":"C/C(O)=C(\\C#N)C(=O)Nc1ccc(-c2ccccc2Cl)c(Cl)c1","inchiKey":"DDSLONVJHZPSBB-UVTDQMKNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL484780","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07559"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL494","canonicalSmiles":"CC#CCC(C)[C@H](O)/C=C/[C@@H]1[C@H]2C/C(=C/CCCC(=O)O)C[C@H]2C[C@H]1O","inchiKey":"HIFJCPQKFCZDDL-ACWOEMLNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ILOPROST","yearOfFirstApproval":2004,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ventavis"],"synonyms":["Ciloprost","Iloprost","ZK 00036374","ZK-00036374","ZK-36374"],"crossReferences":{"DailyMed":["iloprost"],"drugbank":["DB01088"],"chEBI":["63916"]},"count":14,"approvedIndications":["HP_0004419"],"linkedTargets":{"rows":["ENSG00000160013"],"count":1},"linkedDiseases":{"rows":["EFO_0003943","MONDO_0005149","EFO_0001361","EFO_0006834","MONDO_0100130","EFO_0001071","EFO_1001145","EFO_0000537","EFO_0000270","EFO_0003144","MONDO_0008903","EFO_0003884","EFO_1001373","EFO_0000612","EFO_0000341","HP_0004419","EFO_0000717","EFO_0009492","EFO_0004265"],"count":19},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2004 and is indicated for recurrent thrombophlebitis and has 13 investigational indications."}
{"id":"CHEMBL53929","canonicalSmiles":"NCC(O)c1ccc(O)cc1","inchiKey":"QHGUCRYDKWKLMG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OCTOPAMINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ND 50","Octopamine"],"crossReferences":{"PubChem":["104171205","144203766","170465959","90341287"],"Wikipedia":["Octopamine"],"drugbank":["DB13251"],"chEBI":["17134"]},"childChemblIds":["CHEMBL1367565"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL574003","canonicalSmiles":"c1ccc(C(OC2CCN(CCCc3nnn[nH]3)CC2)c2ccccc2)cc1","inchiKey":"TZQGXAHOROZEKN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HQL-79","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["HQL-79"],"crossReferences":{"drugbank":["DB07917"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL609980","canonicalSmiles":"NCCO[N+](=O)[O-]","inchiKey":"KZTZJUQNSSLNAG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AMINOETHYL NITRATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Aminoethyl nitrate","Nitroethanolamine"],"crossReferences":{"drugbank":["DB13585"]},"childChemblIds":["CHEMBL2106780"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL629","canonicalSmiles":"CN(C)CCC=C1c2ccccc2CCc2ccccc21","inchiKey":"KRMDCWKBEZIMAB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"AMITRIPTYLINE","yearOfFirstApproval":1961,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Amitid","Amitril","Amitriptyline","Elavil","Endep","Etrafon-A","Etrafon-Forte","Limbitrol"],"crossReferences":{"DailyMed":["amitriptyline%20hydrochloride"],"PubChem":["11110782","11110783","124879280","90340850"],"TG-GATEs":["70"],"Wikipedia":["Amitriptyline"],"drugbank":["DB00321"],"chEBI":["2666"]},"childChemblIds":["CHEMBL1200964"],"count":19,"approvedIndications":["EFO_0003761"],"linkedTargets":{"rows":["ENSG00000108576","ENSG00000103546"],"count":2},"linkedDiseases":{"rows":["EFO_0005762","EFO_0005687","HP_0000989","HP_0012532","MONDO_0002009","EFO_0000555","EFO_0003821","HP_0000726","EFO_0008507","EFO_0009387","EFO_0003843","EFO_0004698","HP_0002315","EFO_0007169","EFO_1000941","MONDO_0002050","EFO_0010282","EFO_0000512","HP_0030833","EFO_1000632","EFO_0003761","EFO_0004149","EFO_1001800","EFO_0005230","EFO_0000692","EFO_0000400"],"count":26},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1961 and is indicated for unipolar depression and has 18 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL65067","canonicalSmiles":"O=C(C(c1ccccc1)c1ccccc1)N1CCN(CC(O)COc2cccc3ncccc23)CC1","inchiKey":"KLWUUPVJTLHYIM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DOFEQUIDAR","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dofequidar"],"crossReferences":{"drugbank":["DB14067"]},"childChemblIds":["CHEMBL3116252"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL690","canonicalSmiles":"CC[C@H](C)C(=O)O[C@H]1C[C@H](O)C=C2C=C[C@H](C)[C@H](CC[C@@H](O)C[C@@H](O)CC(=O)[O-])[C@H]21.[Na+]","inchiKey":"VWBQYTRBTXKKOG-IYNICTALSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"PRAVASTATIN SODIUM","yearOfFirstApproval":1991,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1144","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Elisor","Lipemol","Liplat","Lipostat","Pravachol","Pravastatin sodium"],"synonyms":["CS-514","Eptastatin sodium","Pravastatin sodium","SQ-31,000","SQ-31000"],"crossReferences":{"DailyMed":["pravastatin%20sodium"],"PubChem":["144205027","144210590","26753280"],"chEBI":["8361"]},"count":9,"approvedIndications":["HP_0003124"],"linkedTargets":{"rows":["ENSG00000113161"],"count":1},"linkedDiseases":{"rows":["HP_0002140","HP_0003124","EFO_0000180","EFO_1000727","EFO_0000537","EFO_0003913","EFO_0000565","MONDO_0002691","EFO_0001359","Orphanet_79211","EFO_0000764","MONDO_0008903","EFO_0001360","EFO_0003918","EFO_0005672"],"count":15},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1991 and is indicated for hypercholesterolemia and has 8 investigational indications."}
{"id":"CHEMBL8224","canonicalSmiles":"CCc1cc(OC)c(CC(C)N)cc1OC","inchiKey":"HXJKWPGVENNMCC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL8224","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"Wikipedia":["2,5-Dimethoxy-4-ethylamphetamine"],"drugbank":["DB01467"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL83088","canonicalSmiles":"Nc1cc2ccccc2c2ccccc12","inchiKey":"KIHQWOBUUIPWAN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"Phenanthren-9-Ylamine","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Phenanthren-9-Ylamine"],"crossReferences":{"drugbank":["DB03369"],"chEBI":["50475"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL864","canonicalSmiles":"CN(C)CCOC(c1ccc(Cl)cc1)c1ccccn1","inchiKey":"OJFSXZCBGQGRNV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CARBINOXAMINE","yearOfFirstApproval":2003,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Carbinoxamine","Clistin","Palgic"],"crossReferences":{"DailyMed":["carbinoxamine%20maleate"],"PubChem":["29217899"],"Wikipedia":["Carbinoxamine"],"drugbank":["DB00748"],"chEBI":["3398"]},"childChemblIds":["CHEMBL1200974","CHEMBL1519829"],"count":1,"approvedIndications":["EFO_0003785"],"linkedTargets":{"rows":["ENSG00000196639"],"count":1},"linkedDiseases":{"rows":["EFO_0005531","EFO_0007533","EFO_0007141","EFO_0005532","EFO_1001417","EFO_0003956","EFO_0003785"],"count":7},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2003 and is indicated for allergy."}
{"id":"CHEMBL867","canonicalSmiles":"CCC(Cc1c(I)cc(I)c(N)c1I)C(=O)O","inchiKey":"OIRFJRBSRORBCM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IOPANOIC ACID","yearOfFirstApproval":1951,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Telepaque"],"synonyms":["Iodopanoic acid","Iopanoic Acid","Iopanoic acid","Jopanoic acid"],"crossReferences":{"PubChem":["144203945","144213787","170465056","26748863","56463181"],"Wikipedia":["Iopanoic_acid"],"drugbank":["DB08946"],"chEBI":["5951"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1951."}
{"id":"CHEMBL894","canonicalSmiles":"CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1","inchiKey":"SNPPWIUOZRMYNY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"BUPROPION","yearOfFirstApproval":1985,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Bupropion"],"crossReferences":{"DailyMed":["bupropion%20hydrobromide","bupropion%20hydrochloride"],"PubChem":["174006913","90340803"],"Wikipedia":["Bupropion"],"drugbank":["DB01156"],"chEBI":["3219"]},"childChemblIds":["CHEMBL1698","CHEMBL1201735"],"count":28,"approvedIndications":["MONDO_0002050","EFO_0003761"],"linkedTargets":{"rows":["ENSG00000103546","ENSG00000142319"],"count":2},"linkedDiseases":{"rows":["EFO_0004320","EFO_0002610","MONDO_0002009","Orphanet_905","HP_0000726","EFO_0000249","EFO_0003768","EFO_0004318","EFO_0003829","MONDO_0002046","Orphanet_68380","EFO_0007191","EFO_0004247","EFO_0000289","MONDO_0002050","EFO_0004714","MONDO_0008903","EFO_0003761","EFO_0009854","EFO_0004701","EFO_0005230","EFO_0000692","EFO_0002617","EFO_0000616","EFO_0004319","EFO_0005203","EFO_0003888","EFO_0006859","EFO_0009963","EFO_0000313","EFO_0001073","EFO_0000384","Orphanet_95","MONDO_0008315","EFO_0003060","Orphanet_399","EFO_0008623","EFO_0003890","MONDO_0002491","EFO_0000095","EFO_0001360","EFO_0004270","EFO_0005411"],"count":43},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1985 and is indicated for unipolar depression and depressive disorder and has 26 investigational indications. This drug has a black box warning from the FDA."}
